Rejuvenating immunity: "anti-aging drug today" eight years later

30Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding 'a turning point' in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will be abolished?

Cite

CITATION STYLE

APA

Blagosklonny, M. V. (2015). Rejuvenating immunity: “anti-aging drug today” eight years later. Oncotarget, 6(23), 19405–19412. https://doi.org/10.18632/oncotarget.3740

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free